Filed before 2025Filed 12 April 2024
Sparrow Pharmaceuticals, Inc. raised $10M
Sparrow Pharmaceuticals, Inc., a pharmaceuticals company based in Portland, OR, raised $10M in a new debt round, according to a filing dated 12 April 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 April 2024
- Round
- Debt round
- Amount sold
- $10M
- Offering size
- $15.3M
- Investors so far
- 4
- Based in
- Portland, OR
- Website
- sparrowpharma.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 58% of the 1,434 tracked raises with an amount filed in 2024.
Sparrow Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 1 Jul 2025 | New filing | $61.8M | Another raise |
| 12 Apr 2024 | New filing | $10M | This raise |
More with U.S. Venture on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.